Info Service on Health Issues (Mar19/05)
Dear friends and colleagues,
The latest WHO and ECDC (European Centre for Disease Prevention and Control) report shows that despite an overall decline in TB incidence and mortality, the disease remains a major public health challenge in the region, especially multidrug-resistant (MDR) TB.
The joint WHO/ECDC report covers TB incidence and mortality for both the WHO European Region, which includes 52 countries, and the 31-country European Union-European Economic Area (EU-EEA).
Much of the gap in estimated incidence rates between the WHO European Region and the EU-EEA is driven by 18-high prevalence non-EU-EEA countries including Russia, Ukraine, Uzbekistan, Romania, Turkey and Kazakhstan that account for nearly 83 percent of the regional TB burden. The largest proportion of new and relapse TB cases comes from Russia (35.4 percent).
Extensively drug-resistant (XDR) TB is also a rising problem in WHO European Region countries. XDR-TB was reported for 24.4 percent of 770 MDR-TB cases tested for second-line drug susceptibility in EU-EEA countries. An increasing trend in XDR-TB was observed in Latvia, Lithuania, Estonia, Romania and Armenia.
The report Tuberculosis surveillance and monitoring in Europe 2019 (2017 data) is available here: https://ecdc.europa.eu/sites/portal/files/documents/tuberculosis-surveillance-monitoring-Europe-2019-20_Mar_2019.pdf